We are live on
!
Find out more
SP
Sarasin & Partners Portfolio holdings
AUM
$8.54B
1-Year Est. Return
9.6%
This Fund
S&P 500
This Quarter
Est. Return
+3.26%
1 Year Est. Return
+9.6%
3 Year Est. Return
+77.95%
5 Year Est. Return
+86.04%
10 Year Est. Return
+393.05%
AUM
$7.02B
AUM Growth
–
Cap. Flow
+$7.06B
Cap. Flow
% of AUM
100.55%
Top 10 Holdings %
Top 10 Hldgs %
35.63%
Holding
136
New
136
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$305M |
| 2 |
Hartford Financial Services
HIG
|
+$280M |
| 3 |
Coca-Cola
KO
|
+$271M |
| 4 |
Home Depot
HD
|
+$264M |
| 5 |
Citigroup
C
|
+$250M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Communication Services | 14.69% |
| 2 | Consumer Discretionary | 14.52% |
| 3 | Financials | 13.79% |
| 4 | Industrials | 9.55% |
| 5 | Consumer Staples | 7.99% |
Similar funds
PCM
IC
NB
GRQ
ACM
DM
FT
PCIA
Sarasin & Partners's Q2 2013 Portfolio in Review
Q2 2013 is the first quarter with a 13F filing on record for Sarasin & Partners, which disclosed 136 positions worth $7.02B. Its ten largest holdings account for 36% of the portfolio.
Its largest position is Pfizer: 11,040,890 shares worth $293M.
By sector, the portfolio is most concentrated in Communication Services at 15% of assets, followed by Consumer Discretionary and Financials.
- Sarasin & Partners's largest Q2 2013 buy was Pfizer: 11,040,890 shares worth $293M.
- Sarasin & Partners's ten largest holdings make up 36% of its $7.02B portfolio in Q2 2013.
- Sarasin & Partners disclosed 136 positions in Q2 2013, its first 13F filing on record.
Based on Sarasin & Partners's 13F filing for Q2 2013, filed 7 Aug 2013.